弥散性血管内凝血诊断与相关分子标志物

严思棋; 郭涛

doi:10.13201/j.issn.1004-2806.2019.01.004

弥散性血管内凝血诊断与相关分子标志物

严思棋,
郭涛^,

- 华中科技大学同济医学院附属协和医院血液科(武汉, 430022)

详细信息

通讯作者: 郭涛,E-mail:guotao1968@163.com

中图分类号: R554.8

收稿日期: 2018-12-03

Diagnosis and related molecular markers of disseminated intravascular coagulation

YAN Siqi,
GUO Tao^,

More Information

Corresponding author: GUO Tao, E-mail: guotao1968@163.com

Received Date: 03 December 2018

摘要

- 弥散性血管内凝血 /
- 诊断 /
- 分子标志物
- disseminated intravascular coagulation /
- diagnosis /
- molecular markers

HTML全文

参考文献(18)

[1]	Polderman KH, Girbes AR.Drug intervention trials in sepsis:divergent results[J].Lancet, 2004, 363:1721-1723.
[2]	Saracco P, Vitale P, Scolfaro C, et al.The coagulopathy in sepsis:significance and implications for treatment[J].Pediatr Rep, 2011, 3:e30.
[3]	Wada H, Matsumoto T, Yamashita Y, et al.Disseminated intravascular coagulation:Testing and diagnosis[J].Clin Chim Acta, 2014, 436:130-134.
[4]	Wada H, Hatada T, Okamoto K, et al.Modified nonovert DIC diagnostic criteria predict the early phase of overt-DIC[J].Am J Hematol, 2010, 85:691-694.
[5]	Ma G, Liu F, Lv L, et al.Increased promyelocyticderived micro particles:a novel potential factor for coagulopathy in acute promyelocytic leukemia[J].Ann Hematol, 2013, 92:645-652.
[6]	Liu Y, Wang Z, Jiang M, et al.The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia[J].Leuk Res, 2011, 35:879-884.
[7]	Madoiwa S, Tanaka H, Nagahama Y, et al.Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation[J].Thromb Res, 2011, 127:349-355.
[8]	Esmon CT.Protein C anticoagulant system-anti-inflammatory effects[J].Semin Immunopathol, 2012, 34:127-132.
[9]	Chu AJ.Tissue factor, blood coagulation, and beyond:an overview[J].Int J Inflamm, 2011, 2011:367284.
[10]	Hayakawa M, Sawamura A, Gando S, et al.A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis[J].Thromb Res, 2012, 130:906-913.
[11]	Wu Y, Luo L, Niu T, et al.Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients:A multicenter prospective study[J].Sci Rep, 2017, 22:9057.
[12]	Levi M, Sivapalaratnam S.Disseminated intravascular coagulation:an update on pathogenesis and diagnosis[J].Expert Rev Hematol, 2018, 11:663-672.
[13]	Tipoe TL, Wu WKK, Chung L, et al.Plasminogen activator inhibitor 1for predicting sepsis severity and mortality outcomes:a systematic review and meta-analysis[J].Front Immunol, 2018, 9:1218.
[14]	Umemura Y, Yamakawa K, Kiguchi T, et al.Design and evaluation of new unified criteria for disseminated intravascular coagulation based on the Japanese Association for Acute Medicine criteria[J].Clin Appl Thromb Hemost, 2016, 22:153-160.
[15]	Yanagida Y, Gando S, Sawamura A, et al.Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma:comparison with acute coagulopathy of trauma-shock[J].Surgery, 2013, 154:48-57.
[16]	Koyama K, Madoiwa S, Nunomiya S, et al.Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis:a prospective observational study[J].Crit Care, 2014, 18:R13.
[17]	Kawasugi K, Wada H, Hatada T, et al.Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases[J].Thromb Res, 2011, 128:186-190.
[18]	Iba T, Ito T, Maruyama I, et al.Potential diagnostic markers for disseminated intravascular coagulation of sepsis[J].Blood Rev, 2016, 30:149-155.